|
|
||||||||
Original Articles |
N-acetylcysteine (NAC) has been employed in the treatment of acute lung injury but its therapeutic value is as yet unproven. In the present study we examined the effect of both L- and D-forms of NAC as inhibitors of bleomycin-induced fibrosis in mice. We hypothesized that, because of the D-form is not metabolized, it may be more effective than the L-form in ameliorating lung injury and fibrosis. Both drugs were given daily in the drinking water at a dose of approximately 400 mg.kg-1 body weight commencing one week prior to a single intratracheal instillation of bleomycin at a dose of 6 mg.kg-1 body weight. Lung injury was assessed 35 days later by measuring total lung collagen content, lung wet weight and examination of tissues by light and electron microscopy. Total collagen content and lung wet weight of animals receiving bleomycin together with L-NAC were 2.90 +/- 0.03 mg and 0.23 +/- 0.01 g, respectively. The values for collagen content, but not wet weight, were significantly less (p less than 0.05) than those given for bleomycin alone (3.90 +/- 0.02 mg and 0.260 +/- 0.005 g, respectively), but greater than (p less than 0.05) controls (2.10 +/- 0.01 mg and 0.160 +/- 0.002 g, respectively). Values for collagen content and wet weight of animals given bleomycin together with D-NAC (3.10 +/- 0.02 mg and 0.21 +/- 0.01 mg, respectively) were both significantly greater than values for control animals but lower than animals given bleomycin alone.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
A. J. Marian, V. Senthil, S. N. Chen, and R. Lombardi Antifibrotic Effects of Antioxidant N-Acetylcysteine in a Mouse Model of Human Hypertrophic Cardiomyopathy Mutation J. Am. Coll. Cardiol., February 21, 2006; 47(4): 827 - 834. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Rubio, M. C. Martin-Mosquero, M. Ortega, G. Peces-Barba, and N. Gonzalez-Mangado Oral N-Acetylcysteine Attenuates Elastase-Induced Pulmonary Emphysema in Rats Chest, April 1, 2004; 125(4): 1500 - 1506. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mata, A. Ruiz, M. Cerda, M. Martinez-Losa, J. Cortijo, F. Santangelo, A. Serrano-Mollar, A. Llombart-Bosch, and E.J. Morcillo Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats Eur. Respir. J., December 1, 2003; 22(6): 900 - 905. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Serrano-Mollar, D Closa, J Cortijo, E J Morcillo, N Prats, M Gironella, J Panes, J Rosello-Catafau, and O Bulbena P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine Thorax, July 1, 2002; 57(7): 629 - 634. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-D. WANG, M. YAMAYA, S. OKINAGA, Y.-X. JIA, M. KAMANAKA, H. TAKAHASHI, L.-Y. GUO, T. OHRUI, and H. SASAKI Bilirubin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 406 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cortijo, M. Cerda-Nicolas, A. Serrano, G. Bioque, J.M. Estrela, F. Santangelo, A. Esteras, A. Llombart-Bosch, and E.J. Morcillo Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats Eur. Respir. J., June 1, 2001; 17(6): 1228 - 1235. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yehualaeshet, R. O'Connor, A. Begleiter, J. E. Murphy-Ullrich, R. Silverstein, and N. Khalil A CD36 Synthetic Peptide Inhibits Bleomycin-Induced Pulmonary Inflammation and Connective Tissue Synthesis in the Rat Am. J. Respir. Cell Mol. Biol., August 1, 2000; 23(2): 204 - 212. [Abstract] [Full Text] |
||||
![]() |
S.-I. HAGIWARA, Y. ISHII, and S. KITAMURA Aerosolized Administration of N-Acetylcysteine Attenuates Lung Fibrosis Induced by Bleomycin in Mice Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 225 - 231. [Abstract] [Full Text] |
||||
![]() |
J. Meulenbelt, L. van Bree, J.A.M.A. Dormans, and B. Sangster No Beneficial Effect of N-acetylcysteine Treatment on Broncho-alveolar Lavage Fluid Variables in Acute Nitrogen Dioxide Intoxicated Rats Human and Experimental Toxicology, January 1, 1994; 13(7): 472 - 477. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |